Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Designed for total beginners, this overview covers the basics of Zero Based Budgeting, with simple actions to start budgeting effectively.
18,919 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
The White House announced that China will buy a minimum of $17 billion in U.S. agricultural goods each year through 2...
Panorama Mortgage Group is folding its various brands into a single banner, SimplyPMG, and naming Fernando Ospina as ...
Investors confront a familiar fork: cash out a top-performing rental to ease debt on another, or hold for long-term g...
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
MicroStrategy holds a record bitcoin stash worth more than its market value, yet MSTR stock is down sharply over the ...
Memory-chip demand has surged with AI and cloud growth, but timing still matters. This guide breaks down how to evalu...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
Midweek is a prime time to refresh your investment plan. This Wednesday Reads guide breaks down tax-smart moves, mark...
As visa rules tighten, a growing share of U.S. firms with immigrant leaders are scrambling to secure continuity throu...
Researchers report clues that AI seems turn marxist after heavy workloads, raising questions for workers and investor...
A synthetic contract puts SpaceX at a $2.4 trillion implied IPO, a figure that dwarfs Facebook's listing and tests ho...